Cargando…
Molecularly Targeted Agents as Radiosensitizers in Cancer Therapy—Focus on Prostate Cancer
As our understanding of the molecular pathways driving tumorigenesis improves and more druggable targets are identified, we have witnessed a concomitant increase in the development and production of novel molecularly targeted agents. Radiotherapy is commonly used in the treatment of various malignan...
Autores principales: | Alcorn, Sara, Walker, Amanda J., Gandhi, Nishant, Narang, Amol, Wild, Aaron T., Hales, Russell K., Herman, Joseph M., Song, Danny Y., DeWeese, Theodore L., Antonarakis, Emmanuel S., Tran, Phuoc T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742274/ https://www.ncbi.nlm.nih.gov/pubmed/23863691 http://dx.doi.org/10.3390/ijms140714800 |
Ejemplares similares
-
Tissue Biomarkers for Prostate Cancer Radiation Therapy
por: Tran, PT, et al.
Publicado: (2012) -
Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888
por: Tuli, Richard, et al.
Publicado: (2014) -
End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
por: Narang, Amol K., et al.
Publicado: (2017) -
Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion
por: Tran, Phuoc T., et al.
Publicado: (2017) -
Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
por: Deek, Matthew P., et al.
Publicado: (2019)